Education
About Us
Working with TipRanks
Follow Us
Evelo Biosciences Inc (EVLO)
OTHER OTC:EVLO
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -108.47M | $ -115.40M | $ -91.89M | $ -86.36M | $ -58.10M |
| EBITDA | $ -106.34M | $ -115.40M | $ -89.86M | $ -84.42M | $ -58.10M |
| Net Income | $ -114.53M | $ -122.18M | $ -93.67M | $ -85.66M | $ -53.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 47.94M | $ 68.44M | $ 68.86M | $ 77.83M | $ 147.92M |
| Total Assets | $ 64.44M | $ 87.87M | $ 90.64M | $ 90.92M | $ 159.87M |
| Total Debt | $ 51.14M | $ 56.29M | $ 40.04M | $ 19.63M | $ 12.30M |
| Net Debt | $ 3.20M | $ -12.15M | $ -28.82M | $ -58.20M | $ -135.61M |
| Total Liabilities | $ 69.43M | $ 79.20M | $ 60.15M | $ 30.72M | $ 22.92M |
| Stockholders' Equity | $ -4.99M | $ 8.67M | $ 30.48M | $ 60.20M | $ 136.95M |
| Cash Flow | |||||
| Free Cash Flow | $ -101.86M | $ -98.24M | $ -74.38M | $ -75.01M | $ -52.74M |
| Operating Cash Flow | $ -101.23M | $ -96.72M | $ -73.06M | $ -71.98M | $ -47.28M |
| Investing Cash Flow | $ -622.00K | $ -1.48M | $ -1.31M | $ 51.97M | $ -60.13M |
| Financing Cash Flow | $ 81.66M | $ 97.54M | $ 65.47M | $ 4.99M | $ 162.01M |
Evelo Biosciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.